Aims and Scope

Journal of Nephropharmacology

eISSN: 2345-4202

A publication of Diabetic Nephropathy Prevention

Nephropharmacology is the intersection between nephrology and clinical Pharmacology.

Journal of Nephropharmacology (J Nephropharmacol) considers the following topics; Mechanisms of drug elimination by the kidneys, drug therapy and renal transplantation, drug therapy of co-morbidity in renal disease patients and renal toxicity of drugs. Also, the specific aspects of pharmacokinetics and drug dose adjustment in patients with disturbed renal function, has significant importance in this journal.

J Nephropharmacol also devoted to herbal medicines and kidney and also treatment of diabetic kidney disease. We also had specific attention to renoprotection.

The journal is a peer-reviewed scientific journal publishes every six months in January andJuly of each year.

This international journal publishes manuscripts in the fields of physiology, kidney transplantation, nephrology and hypertension with regards to the treatment of these disease in both basic and clinical researches. This journal aims to reach all relevant national and international medical institutions and persons in electronic version free of charge.

J Nephropharmacol (e-ISSN: 2345-4202), is a publication of Diabetic Nephropathy Prevention.
It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views, discussion, photo-clinic and renal biopsy teaching point. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy. A further aim of this journal is to emphasize and strengthen the link between nephrologists and pharmacologists. In addition, J Nephropharmacol welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology. Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted. Contributions in any of these formats are invited for editorial consideration following peer review by at least three experts in the field.

Publisher and owner: Diabetic Nephropathy Prevention